Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

 SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.The company... 
More about the company
Surperformance© ratings of 3SBio Inc. (ADR)
Trading Rating : Investor Rating :
More Ratings
Latest news on 3SBIO INC. (ADR)
01/27 3SBIO : to add stake in CP Guojian Pharmaceutical
01/20 3SBIO : to add stake in CP Guojian
01/05DJChinese Drugmaker Plans up to $3 Billion Hong Kong IPO
01/05DJChina's Jiangsu Hansoh Pharmaceutical Plans up to $3 Billion Hong Kong IPO
2015 3SBIO : Goldman starts 3SBio Inc at HK$11.1
2015 3SBIO : to add stake in biopharmaceutical firm
2015 3SBIO : Signs Exclusive Patent License Agreement for ALT-P7, an Antibody-drug Co..
2015 3SBIO : Inks Licensing Agreement with Alteogen
More news
Sector news : Bio Therapeutic Drugs
05:07p AMGEN : To Present At The Leerink Partners 5th Annual Global Healthcare Conferen..
04:30p AMGEN : Positive topline results from GAUSS-3 trial of Repatha
04:30p SANOFI : Muzammil Mansuri is Sanofi’s new Executive Committee member
More sector news : Bio Therapeutic Drugs
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions